Description
The presence of ROS1 gene translocation is a predictor of response to therapy with ROS1 inhibitors in patients with locally advanced and metastatic non-small cell lung cancer.
Period of execution
Within 12 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Tissue sample
- Tissue sample in paraffin block